About Index Trending news
Lists
Pricing
Intercept Pharmaceuticals

Intercept Pharmaceuticals

Intercept Pharmaceuticals

Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases.

Elsewhere

Alexa global traffic share

01 Apr 2015
$338,400,000
Post-IPO equity
10 Aug 2012
$30,000,000
Venture capital (Series C)